2FF-90902-12624
2 vaccinations
7 coded responses
19 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 315 / GA
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 1 — Moderna
-
2021-03-22
Survey response — day 0, dose 1MedDRA: Injection site bruising — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Bruising around injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising, Injection site discolouration — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Purple/blue bruising around injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising, Injection site induration — Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: A hard mass developed below bruised injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-29
- 2021-04-08
- 2021-04-12
-
2021-04-19
Dose 2 — Moderna
-
2021-04-19
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-04-20
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-04-26
- 2021-05-03
- 2021-05-12
-
2021-05-24
Survey response — day 35, dose 2MedDRA: Arthralgia — Feeling: GoodFree text: Joint painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-31
Survey response — day 42, dose 2MedDRA: Arthralgia — Feeling: GoodFree text: Joint pain, especially hip and knee, continue to worsenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-19
Survey response — 3 months, dose 2MedDRA: Alopecia, Amnesia, Arthralgia, Fatigue, Medical counselling — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Joint pain, often severe. Memory loss/deceased memory retention. Hair loss. Fatigue. · Healthcare visit (other): Discussion reviewing symptoms with other health care professionalsMedDRA releases: 2024-11 · check-in free text available
-
2021-07-19
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-27
-
2021-10-22
Survey response — 6 months, dose 2MedDRA: Arthralgia, Fatigue, Headache, Memory impairment — Feeling: GoodFree text: Persistent fatigue, significant decrease in ability to retain information, headaches, persistent and increased joint painMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Moderna | |
| 2 | 2021-04-19 | Moderna |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Bruising around injection site
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Purple/blue bruising around injection site
Systemic reaction (other): A hard mass developed below bruised injection site
Release 8 — day 35, dose 2
Symptoms: Joint pain
Release 8 — day 42, dose 2
Symptoms: Joint pain, especially hip and knee, continue to worsen
Release 9 — 3 months, dose 2
Symptoms: Joint pain, often severe. Memory loss/deceased memory retention. Hair loss. Fatigue.
Healthcare visit (other): Discussion reviewing symptoms with other health care professionals
Release 10 — 6 months, dose 2
Symptoms: Persistent fatigue, significant decrease in ability to retain information, headaches, persistent and increased joint pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Alopecia | · | · | ✓ |
| SD | Amnesia | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Memory impairment | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site discolouration | · | · | ✓ |
| SRO | Injection site induration | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release